TR200002971T2 - İkameli pirolidin hidroksamat metaloproteaz inhibitörleri - Google Patents
İkameli pirolidin hidroksamat metaloproteaz inhibitörleriInfo
- Publication number
- TR200002971T2 TR200002971T2 TR2000/02971T TR200002971T TR200002971T2 TR 200002971 T2 TR200002971 T2 TR 200002971T2 TR 2000/02971 T TR2000/02971 T TR 2000/02971T TR 200002971 T TR200002971 T TR 200002971T TR 200002971 T2 TR200002971 T2 TR 200002971T2
- Authority
- TR
- Turkey
- Prior art keywords
- compounds
- provides
- substituted pyrrolidine
- metalloprotease inhibitors
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
- C07D207/48—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Ophthalmology & Optometry (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Enzymes And Modification Thereof (AREA)
- Pyrrole Compounds (AREA)
Abstract
Bulus, metaloproteazlarin etkili inhibitörleri olan ve bu enzimlerin asiri aktivitesi ile iliskili hastaliklarin tedavi edilmesinde etkili olan bilesikler saglar. Özel olarak, bu bulus, Formül (I)'e uygun bir yapiya sahip bilesik saglar: buradaki R1,R2,X,Z,m ve n, asagida tanimlanmistir. Bu bulus, ayrica formül (I)'in optik izomerlerini, diyastereomerlerini ve enantiyomerlerini ve bunlarin farmasötik olarak kabul edilebilir tuzlarini, biyolojik olarak hidrolize olabilir amidlerini,esterlerini ve imidlerini de içerir. Bu bulusun bilesikleri, istenmeyen metaloproteaz aktivitesiyle iliskili hastaliklarin ve durumlarin tedavisinde faydalidirlar. Buna göre, bulus, bu bilesikleri içeren farmasötik bilesimler saglar. Bulus ayrica bu bilesikleri ve bunlari içeren farmasötik bilesimleri kullanarak metaloproteaz ile iliskili hastaliklarin tedavisi için yöntemler de saglar.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8166798P | 1998-04-14 | 1998-04-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200002971T2 true TR200002971T2 (tr) | 2001-02-21 |
Family
ID=22165611
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2000/02971T TR200002971T2 (tr) | 1998-04-14 | 1999-04-09 | İkameli pirolidin hidroksamat metaloproteaz inhibitörleri |
Country Status (21)
Country | Link |
---|---|
US (1) | US6329418B1 (tr) |
EP (1) | EP1073635A1 (tr) |
JP (1) | JP2002511448A (tr) |
KR (1) | KR100400507B1 (tr) |
CN (1) | CN1297436A (tr) |
AR (1) | AR029145A1 (tr) |
AU (1) | AU753048B2 (tr) |
BR (1) | BR9909620A (tr) |
CA (1) | CA2328211A1 (tr) |
CO (1) | CO5011039A1 (tr) |
HU (1) | HUP0102195A3 (tr) |
ID (1) | ID26925A (tr) |
IL (1) | IL138738A0 (tr) |
NO (1) | NO20005196L (tr) |
NZ (1) | NZ507076A (tr) |
PE (1) | PE20000425A1 (tr) |
PL (1) | PL343529A1 (tr) |
SK (1) | SK15462000A3 (tr) |
TR (1) | TR200002971T2 (tr) |
WO (1) | WO1999052868A1 (tr) |
ZA (1) | ZA200005047B (tr) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6403632B1 (en) * | 2000-03-01 | 2002-06-11 | Bristol Myers Squibb Pharma Co | Lactam metalloprotease inhibitors |
SI1268418T1 (sl) * | 2000-03-27 | 2006-10-31 | Applied Research Systems | Farmacevtsko aktivni pirolidinski derivati kot bax-inhibitorji |
ES2261404T3 (es) * | 2000-03-27 | 2006-11-16 | Applied Research Systems Ars Holding N.V. | Derivados de pirrolidina utiles como inhibidores de bax. |
US8283135B2 (en) | 2000-06-30 | 2012-10-09 | The Procter & Gamble Company | Oral care compositions containing combinations of anti-bacterial and host-response modulating agents |
WO2002006271A1 (en) | 2000-07-19 | 2002-01-24 | F. Hoffmann-La Roche Ag | Pyrimidine derivatives |
FR2819252A1 (fr) * | 2001-01-11 | 2002-07-12 | Servier Lab | Nouveaux derives d'acide hydroxamique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
SE0100902D0 (sv) * | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
SE0100903D0 (sv) * | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
JP4350948B2 (ja) * | 2001-03-20 | 2009-10-28 | ラボラトワール セローノ ソシエテ アノニム | オキシトシン調節活性を有するピロリジンエステル誘導体 |
SE0103710D0 (sv) * | 2001-11-07 | 2001-11-07 | Astrazeneca Ab | Compounds |
UA78058C2 (en) * | 2002-07-05 | 2007-02-15 | Applied Research Systems | Pyrrolidine derivative as oxitocin antagonists |
SE0202539D0 (sv) | 2002-08-27 | 2002-08-27 | Astrazeneca Ab | Compounds |
GB0221246D0 (en) * | 2002-09-13 | 2002-10-23 | Astrazeneca Ab | Compounds |
CN1294120C (zh) * | 2003-10-21 | 2007-01-10 | 山东大学 | 吡咯烷类基质金属蛋白酶抑制剂及其应用 |
BRPI0508059A (pt) * | 2004-02-26 | 2007-07-17 | Applied Research Systems | método para preparação de pirrolidina oximas |
US7648992B2 (en) | 2004-07-05 | 2010-01-19 | Astrazeneca Ab | Hydantoin derivatives for the treatment of obstructive airway diseases |
SE0401762D0 (sv) * | 2004-07-05 | 2004-07-05 | Astrazeneca Ab | Novel compounds |
WO2006038265A1 (ja) * | 2004-09-30 | 2006-04-13 | Yutaka Imauchi | 耳硬化症治療のための医薬組成物 |
SE0403085D0 (sv) * | 2004-12-17 | 2004-12-17 | Astrazeneca Ab | Novel componds |
SE0403086D0 (sv) * | 2004-12-17 | 2004-12-17 | Astrazeneca Ab | Compounds |
TW200831488A (en) * | 2006-11-29 | 2008-08-01 | Astrazeneca Ab | Novel compounds |
NZ596445A (en) | 2009-06-24 | 2013-04-26 | Boehringer Ingelheim Int | New compounds, pharmaceutical composition and methods relating thereto |
WO2010149685A1 (en) | 2009-06-24 | 2010-12-29 | Boehringer Ingelheim International Gmbh | New compounds, pharmaceutical composition and methods relating thereto |
EP2845850A1 (en) | 2013-09-10 | 2015-03-11 | ObsEva S.A. | Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonists |
EP2886107A1 (en) | 2013-12-17 | 2015-06-24 | ObsEva S.A. | Oral formulations of pyrrolydine derivatives |
JP2017519015A (ja) | 2014-07-02 | 2017-07-13 | オブセヴァ エス.エー. | Ot−r活性に関する疾患を治療するための方法に有用な結晶質の(3z,5s)−5−(ヒドロキシメチル)−1−[(2’−メチル−1,1’−ビフェニル−4−イル)カルボニル]ピロリジン−3−オン о−メチルオキシム |
Family Cites Families (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3380992A (en) * | 1965-06-14 | 1968-04-30 | Upjohn Co | Lincomycin derivatives and process for preparing same |
US4377701A (en) * | 1981-09-21 | 1983-03-22 | E. R. Squibb & Sons, Inc. | 4-Methylene-1-[[(alranoyl or arylcarbonyl)mercapto]acyl]proline and pipecolic acid |
US4743587A (en) | 1985-09-10 | 1988-05-10 | G. D. Searle & Co. | Hydroxamic acid based collagenase inhibitors |
US4771038A (en) | 1986-01-21 | 1988-09-13 | Ici Americas Inc. | Hydroxamic acids |
DK77487A (da) | 1986-03-11 | 1987-09-12 | Hoffmann La Roche | Hydroxylaminderivater |
ZW23187A1 (en) | 1986-12-15 | 1988-06-29 | Hoffmann La Roche | Phosphinic acid derivatives |
US5892112A (en) | 1990-11-21 | 1999-04-06 | Glycomed Incorporated | Process for preparing synthetic matrix metalloprotease inhibitors |
US5183900A (en) | 1990-11-21 | 1993-02-02 | Galardy Richard E | Matrix metalloprotease inhibitors |
GB9102635D0 (en) | 1991-02-07 | 1991-03-27 | British Bio Technology | Compounds |
GB9107368D0 (en) | 1991-04-08 | 1991-05-22 | Smithkline Beecham Plc | Novel compounds |
WO1992022523A2 (en) | 1991-06-14 | 1992-12-23 | Research Corporation Technologies, Inc. | Peptide derivatives of collagenase inhibitor |
JPH05125029A (ja) | 1991-11-06 | 1993-05-21 | Yamanouchi Pharmaceut Co Ltd | 新規なアミド化合物又はその塩 |
CA2126687A1 (en) | 1992-01-15 | 1993-07-22 | Charles G. Caldwell | Substituted phosphinic acid-containing peptidyl derivatives as antidegenerative agents |
AU4267293A (en) | 1992-05-01 | 1993-11-29 | British Biotech Pharmaceuticals Limited | Use of MMP inhibitors |
US5318964A (en) | 1992-06-11 | 1994-06-07 | Hoffmann-La Roche Inc. | Hydroxamic derivatives and pharmaceutical compositions |
AU666727B2 (en) | 1992-06-25 | 1996-02-22 | F. Hoffmann-La Roche Ag | Hydroxamic acid derivatives |
GB9215665D0 (en) | 1992-07-23 | 1992-09-09 | British Bio Technology | Compounds |
GB9223904D0 (en) | 1992-11-13 | 1993-01-06 | British Bio Technology | Inhibition of cytokine production |
US5506242A (en) | 1993-01-06 | 1996-04-09 | Ciba-Geigy Corporation | Arylsufonamido-substituted hydroxamic acids |
US5455258A (en) | 1993-01-06 | 1995-10-03 | Ciba-Geigy Corporation | Arylsulfonamido-substituted hydroxamic acids |
GB9308695D0 (en) | 1993-04-27 | 1993-06-09 | Celltech Ltd | Peptidyl derivatives |
DE69419473T2 (de) | 1993-04-27 | 2000-03-16 | Celltech Therapeutics Ltd. | Peptidylderivate als inhibitoren von metalloproteinase |
DE69415159T2 (de) | 1993-08-02 | 1999-07-22 | Celltech Therapeutics Ltd., Slough, Berkshire | Succinamid-derivate, verfahren zu ihrer herstellung und ihre verwendung als gelatinase- und collagenase- inhibitoren |
GB9316162D0 (en) * | 1993-08-04 | 1993-09-22 | Zeneca Ltd | Fungicides |
US5545735A (en) | 1993-10-04 | 1996-08-13 | Merck & Co., Inc. | Benzo-Fused Lactams promote release of growth hormone |
US5470834A (en) | 1993-10-06 | 1995-11-28 | Florida State University | Sulfoximine and suldodiimine matrix metalloproteinase inhibitors |
US5403952A (en) | 1993-10-08 | 1995-04-04 | Merck & Co., Inc. | Substituted cyclic derivatives as novel antidegenerative agents |
UA48121C2 (uk) | 1993-11-04 | 2002-08-15 | Сінтекс (С.Ш.А.) Інк. | Інгібітори матричних металопротеаз і фармацетична композиція на їх основі |
GB9323165D0 (en) | 1993-11-10 | 1994-01-05 | Chiros Ltd | Compounds |
EP0822186B1 (en) | 1994-01-20 | 2000-03-15 | British Biotech Pharmaceuticals Limited | L-tert-leucine-2-pyridylamide |
GB9401129D0 (en) | 1994-01-21 | 1994-03-16 | British Bio Technology | Hydroxamic acid derivatives as metalloproteinase inhibitors |
KR970700652A (ko) | 1994-01-22 | 1997-02-12 | 포올 리틀우드 | 금속단백질 분해효소 억제제 |
US5514716A (en) | 1994-02-25 | 1996-05-07 | Sterling Winthrop, Inc. | Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof |
GB9404046D0 (en) | 1994-03-03 | 1994-04-20 | Smithkline Beecham Corp | Novel compounds |
GB9405076D0 (en) | 1994-03-16 | 1994-04-27 | Inst Of Ophtalmology | A medical use of matrix metalloproteinase inhibitors |
DE4411311A1 (de) | 1994-03-31 | 1995-10-05 | Basf Ag | Verfahren zur Herstellung von lagerstabilen wäßrigen Lösungen von Vinylamin-Einheiten enthaltenden Polymerisaten |
GB9501737D0 (en) | 1994-04-25 | 1995-03-22 | Hoffmann La Roche | Hydroxamic acid derivatives |
WO1995029892A1 (en) | 1994-04-28 | 1995-11-09 | The Du Pont Merck Pharmaceutical Company | Hydroxamic acid and amino acid derivatives and their use as anti-arthritic agents |
JPH07304770A (ja) | 1994-05-11 | 1995-11-21 | Kanebo Ltd | 新規ベンゾアゼピノン誘導体 |
ATE181055T1 (de) | 1994-05-28 | 1999-06-15 | British Biotech Pharm | Succinyl hydroxamsäure-, n-formyl-n-hydroxy- aminocarbonsäure- und succinsäureamid-derivate und ihre verwendung als metalloprotease- inhibitoren |
GB9411088D0 (en) | 1994-06-03 | 1994-07-27 | Hoffmann La Roche | Hydroxylamine derivatives |
GB9411598D0 (en) | 1994-06-09 | 1994-08-03 | Hoffmann La Roche | Hydroxamic acid derivatives |
GB9412350D0 (en) | 1994-06-20 | 1994-08-10 | Fujisawa Pharmaceutical Co | New compound and its preparation |
CA2193691A1 (en) | 1994-06-22 | 1995-12-28 | Andrew Miller | Metalloproteinase inhibitors |
GB9416897D0 (en) | 1994-08-20 | 1994-10-12 | British Biotech Pharm | Metalloproteinase inhibitors |
TR199800990T2 (tr) | 1995-12-08 | 1998-07-21 | Agouron Pharmaceuticals, Inc. | Metaloproteinaz inhibitörleri, bunlari içeren farmasötik bilesimler, bunlarin farmasötik kullanimlari ve bunlarin üretiminde kullanilabilecek yöntemler ve ara ürünler. |
ATE226193T1 (de) | 1996-08-28 | 2002-11-15 | Procter & Gamble | Substituierte zyklische amine als metalloproteaseinhibitoren |
-
1999
- 1999-03-23 US US09/274,564 patent/US6329418B1/en not_active Expired - Fee Related
- 1999-04-09 WO PCT/US1999/007826 patent/WO1999052868A1/en not_active Application Discontinuation
- 1999-04-09 BR BR9909620-0A patent/BR9909620A/pt not_active IP Right Cessation
- 1999-04-09 AU AU35522/99A patent/AU753048B2/en not_active Ceased
- 1999-04-09 PL PL99343529A patent/PL343529A1/xx unknown
- 1999-04-09 EP EP99917387A patent/EP1073635A1/en not_active Withdrawn
- 1999-04-09 KR KR10-2000-7011405A patent/KR100400507B1/ko not_active IP Right Cessation
- 1999-04-09 TR TR2000/02971T patent/TR200002971T2/tr unknown
- 1999-04-09 HU HU0102195A patent/HUP0102195A3/hu unknown
- 1999-04-09 CA CA002328211A patent/CA2328211A1/en not_active Abandoned
- 1999-04-09 IL IL13873899A patent/IL138738A0/xx unknown
- 1999-04-09 JP JP2000543431A patent/JP2002511448A/ja not_active Withdrawn
- 1999-04-09 NZ NZ507076A patent/NZ507076A/xx unknown
- 1999-04-09 CN CN99805010A patent/CN1297436A/zh active Pending
- 1999-04-09 ID IDW20002350A patent/ID26925A/id unknown
- 1999-04-09 SK SK1546-2000A patent/SK15462000A3/sk unknown
- 1999-04-14 CO CO99022198A patent/CO5011039A1/es unknown
- 1999-04-14 AR ARP990101724A patent/AR029145A1/es not_active Application Discontinuation
- 1999-04-14 PE PE1999000301A patent/PE20000425A1/es not_active Application Discontinuation
-
2000
- 2000-09-21 ZA ZA200005047A patent/ZA200005047B/en unknown
- 2000-10-16 NO NO20005196A patent/NO20005196L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20005196L (no) | 2000-12-14 |
PE20000425A1 (es) | 2000-07-13 |
WO1999052868A1 (en) | 1999-10-21 |
PL343529A1 (en) | 2001-08-27 |
NZ507076A (en) | 2003-04-29 |
NO20005196D0 (no) | 2000-10-16 |
KR20010042694A (ko) | 2001-05-25 |
ZA200005047B (en) | 2001-06-06 |
SK15462000A3 (sk) | 2001-06-11 |
CA2328211A1 (en) | 1999-10-21 |
KR100400507B1 (ko) | 2003-10-08 |
HUP0102195A3 (en) | 2001-12-28 |
ID26925A (id) | 2001-02-22 |
IL138738A0 (en) | 2001-10-31 |
US6329418B1 (en) | 2001-12-11 |
EP1073635A1 (en) | 2001-02-07 |
JP2002511448A (ja) | 2002-04-16 |
HUP0102195A2 (hu) | 2001-11-28 |
AU753048B2 (en) | 2002-10-03 |
CN1297436A (zh) | 2001-05-30 |
AR029145A1 (es) | 2003-06-18 |
CO5011039A1 (es) | 2001-02-28 |
BR9909620A (pt) | 2000-12-19 |
AU3552299A (en) | 1999-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200002971T2 (tr) | İkameli pirolidin hidroksamat metaloproteaz inhibitörleri | |
TR199900431T2 (tr) | Ikame edilmis siklik amin metaloproteaz inhibitörleri | |
NO20024521L (no) | Heterocyklisk sidekjede-inneholdende metalloproteaseinhibitorer | |
HUP9903916A2 (hu) | Foszfinsavamidok és ezeket tartalmazó gyógyszerkészítmények | |
DK0599444T3 (da) | Dobbeltvirkende inhibitorer | |
BR9712086A (pt) | Inibidores1,4-heterocìclicos de metaloproteinases | |
TR200000671T2 (tr) | FP agonistleri olarak yararlı aromatik C16-C20-ikameli tetrahidro prostaglandinler. | |
BR0011130A (pt) | Inibidores de metaloproteases | |
TR199900382T2 (tr) | Heterosiklik metaloproteaz inhibitörleri. | |
HUP0000130A2 (hu) | 1,3-Heterociklusos fémproteáz inhibitorok | |
TR200000670T2 (tr) | FP agonistleri olarak yararlı aromatik C16-C20- ikameli tetrahidro prostaglandinler. | |
TR200000673T2 (tr) | FP agonistleri olarak yararlı aromatik C16-C20- ikameli tetrahidro prostaglandinler. | |
ATE319440T1 (de) | Antidiabetische mittel | |
WO2000051993A3 (en) | Dihetero-substituted metalloprotease inhibitors | |
TR199900401T2 (tr) | Bidentat metaloproteaz inhibitörleri. | |
TR200102523T2 (tr) | Alkenil ve alkinil içeren metaloproteaz inhibitörleri | |
BR0109328A (pt) | Inibidores de metaloprotease n-substituìdos, contendo cadeia lateral heterocìclica | |
WO2001070720A3 (en) | Carbocyclic side chain containing, n-substituted metalloprotease inhibitors | |
TR200002808T2 (tr) | İlaç olarak yararlı C11 oksimil ve hidroksilamino prostaglandinleri | |
TR200200977T2 (tr) | Beta konumunda iki kere sübstitüe edilmiş metaloproteaz engelleyiciler | |
WO2001070682A3 (en) | Carbocyclic side chain containing metalloprotease inhibitors | |
MX9704968A (es) | Inhibidores que contienen acido hidroxamico de metaloproteasas de matriz. |